Read the full story from Medical Design and Outsourcing.
Becton Dickinson (NYSE:BDX) said this week it will spend $8 million to upgrade emissions controls at two medical device sterilization plants it operates in Georgia.
The plants in Covington and Madison, Ga., both southeast of Atlanta, use ethylene oxide (EO) to sterilize medical devices. The federal Environmental Protection Agency recognizes EO as a carcinogen and lowered its limits on emissions of the sterilant gas in 2016. BD acquired the plants when it bought C.R. Bard in 2017.
BD said in a statement that it volunteered to design and install new emission-reduction technologies and processes to further reduce EO emissions at the plants. The company said it gave Georgia Governor Brian Kemp a plan to have an independent company validate its current emissions destruction of 99.95%, which exceeds the 99% regulatory
requirement.
